🔎 Trials Near Me

Akèy › Skleroz an milti pwogresif kwonik › Michigan

Etid klinik pou Skleroz an milti pwogresif kwonik nan Michigan

4 etid pou Skleroz an milti pwogresif kwonik ap chèche patisipan nan sit nan Michigan.

Tèks ofisyèl etid la (Anglè)

A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

  • Profound Research LLC at Oakland Neurology Center, Rochester Hills
Ap rekriteFaz 3
Laj 18 a 60 · Tout sèks · Mizajou Sep 30, 2026 · NCT07299019

Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

  • Henry Ford Neuroscience Institute, Detroit
Ap rekriteFaz 3
Laj 18 a 55 · Tout sèks · Mizajou Sep 16, 2026 · NCT04047628

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

  • Michigan Institute of Neurological, Farmington Hills
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Jul 29, 2026 · NCT07225504

Bringing the Outdoors In: Virtual Nature Walks for Depression in Multiple Sclerosis (MS) Patients

  • University of Michigan, Ann Arbor
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Feb 12, 2026 · NCT07392879

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.